PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
Recalled Product
PAXLOVID (150 mg nirmatrelvir; 100 mg ritonavir)
Hazard / Issue
Labelling - New safety information - Supply - COVID
Issued by
Marketed health products
Were you affected by this recall?
If you were harmed by a recalled product, you may have legal options. Consider speaking with a consumer protection lawyer in your province.
Looking for safe alternatives?
Browse certified-safe products in this category on Amazon Canada →
Get Canada's next recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CASL compliant · No spam · Unsubscribe anytime